Dan Schell

By Dan Schell, Chief Editor, Clinical Leader Usually, when someone sees my name badge at a conference, they say, “Oh, you’re that guy who sends me all those emails.” (For the record, those are not coming from me personally.) Thankfully, that wasn’t what Dan Nicolau, Ph.D., said to me when we met at the Clinical Trials Technology Congress (CTTC) in London earlier this year. Instead, Nicolau, who was familiar with Clinical Leader, told me a story that quickly got my attention.

By Dan Schell, Chief Editor, Clinical Leader Ribu Goyal Talking with folks who work in clinical research at an AMC is always super interesting to me because those environments are often very different (e.g., technology used, operational/management structure) from stand-alone sites. So, when Ribu Goyal, an IRB specialist and scientific reviewer at the Mayo Clinic Office for Human Research Protection, contacted me and offered to tell the story of her journey “from lab to regulations,” I was all in.

Why Diversity Still Should Matter Join Clinical Leader Live Chief Editor Dan Schell and his curated panelist of experts when they take a hard look at inclusivity in clinical trials and what’s holding the industry back. Learn why getting it right in 2026 isn’t optional; it’s essential for science, safety, and patients. Register for Why Diversity Still Should Matter on July 15 at 11 AM ET.